Cargando…
Galantamine treatment in Alzheimer’s disease: response and long-term outcome in a routine clinical setting
BACKGROUND: In the absence of long-term, placebo-controlled studies of cholinesterase inhibitors in Alzheimer’s disease (AD), analysis of the results of open-label trials becomes crucial. This study aimed to explore the three-year effects of galantamine treatment, as well as subgroups of response an...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191869/ https://www.ncbi.nlm.nih.gov/pubmed/22003296 http://dx.doi.org/10.2147/NDT.S24196 |